CordenPharma Boosts Aseptic Fill-Finish Capacity to 500 Million Sterile Injectable Units Per Year

Positive

AI Analysis

Summary

CordenPharma is investing €80 million in a multi-year expansion to increase aseptic fill-finish capacity to 500 million sterile injectable units per year. The investment includes a new facility and additional production lines for its contract manufacturing services.

Importance:3/10

Sentiment:

0.60

CDMOmanufacturing capacityaseptic fill-finishsterile injectablescapital investment

Related Companies

$BMGL

Read the original article

Published by PR Newswire Biotech on September 10, 2026 5:30 AM

Read Original